Bioengineered vein: A first in U.S.

Vascular surgeon Jeffrey H. Lawson, MD, PhD, implanted a bioengineered vein graft June 5 in a patient with end-stage kidney disease in a two-hour procedure at Duke University Hospital in Durham, N.C. The operation launches the U.S. trial of the human cell-based product that Lawson helped develop. If the bioengineered veins prove beneficial for hemodialysis patients, then they may try to develop a graft for heart bypass surgeries.